These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 12738128

  • 21. Application of real-time PCR of sex-independent insertion-deletion polymorphisms to determine fetal sex using cell-free fetal DNA from maternal plasma.
    Ho SS, Barrett A, Thadani H, Asibal CL, Koay ES, Choolani M.
    Clin Chem Lab Med; 2015 Jul; 53(8):1189-95. PubMed ID: 25581758
    [Abstract] [Full Text] [Related]

  • 22. Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination.
    Hromadnikova I, Houbova B, Hridelova D, Voslarova S, Kofer J, Komrska V, Habart D.
    Prenat Diagn; 2003 Mar; 23(3):235-8. PubMed ID: 12627426
    [Abstract] [Full Text] [Related]

  • 23. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A paradigm for prenatal diagnosis and treatment.
    Nimkarn S, New MI.
    Ann N Y Acad Sci; 2010 Mar; 1192():5-11. PubMed ID: 20392211
    [Abstract] [Full Text] [Related]

  • 24. Prenatal fetal adrenal suppression following in utero diagnosis of congenital adrenal hyperplasia.
    Shapiro E, Santiago JV, Crane JP.
    J Urol; 1989 Aug; 142(2 Pt 2):663-6; discussion 667-8. PubMed ID: 2746796
    [Abstract] [Full Text] [Related]

  • 25. Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) in Croatia.
    Dumic M, Brkljacic L, Plavsic V, Zunec R, Ille J, Wilson RC, Kuvacic I, Kastelan A, New MI.
    Am J Med Genet; 1997 Oct 31; 72(3):302-6. PubMed ID: 9332659
    [Abstract] [Full Text] [Related]

  • 26. Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency.
    Mercado AB, Wilson RC, Cheng KC, Wei JQ, New MI.
    J Clin Endocrinol Metab; 1995 Jul 31; 80(7):2014-20. PubMed ID: 7608248
    [Abstract] [Full Text] [Related]

  • 27. First trimester prenatal diagnosis of 21-hydroxylase deficiency by linkage analysis to HLA-DNA probes and by 17-hydroxyprogesterone determination.
    Mornet E, Boue J, Raux-Demay M, Couillin P, Oury JF, Dumez Y, Dausset J, Cohen D, Boué A.
    Hum Genet; 1986 Aug 31; 73(4):358-64. PubMed ID: 3017844
    [Abstract] [Full Text] [Related]

  • 28. New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011).
    Tardy-Guidollet V, Menassa R, Costa JM, David M, Bouvattier-Morel C, Baumann C, Houang M, Lorenzini F, Philip N, Odent S, Guichet A, Morel Y.
    J Clin Endocrinol Metab; 2014 Apr 31; 99(4):1180-8. PubMed ID: 24471566
    [Abstract] [Full Text] [Related]

  • 29. New developments in prenatal diagnosis of congenital adrenal hyperplasia.
    Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T.
    J Steroid Biochem Mol Biol; 2017 Jan 31; 165(Pt A):121-123. PubMed ID: 27378492
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Gene analysis of free fetal DNA in maternal plasma.
    Chen H, Wang T, He G, Zhu L, Ma T.
    J Tongji Med Univ; 2001 Jan 31; 21(4):329-31. PubMed ID: 12539562
    [Abstract] [Full Text] [Related]

  • 32. Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by allele-specific hybridization and Southern blot.
    Speiser PW, White PC, Dupont J, Zhu D, Mercado AB, New MI.
    Hum Genet; 1994 Apr 31; 93(4):424-8. PubMed ID: 8168813
    [Abstract] [Full Text] [Related]

  • 33. [Prevention of sexual ambiguity in children with 21-hydroxylase deficiency by treatment in utero].
    Forest MG, David M.
    Pediatrie; 1992 Apr 31; 47(5):351-7. PubMed ID: 1331950
    [Abstract] [Full Text] [Related]

  • 34. Congenital adrenal hyperplasia in pregnancy.
    Garner PR.
    Semin Perinatol; 1998 Dec 31; 22(6):446-56. PubMed ID: 9880115
    [Abstract] [Full Text] [Related]

  • 35. Earliest gestational age for fetal sexing in cell-free maternal plasma.
    Rijnders RJ, Van Der Luijt RB, Peters ED, Goeree JK, Van Der Schoot CE, Ploos Van Amstel JK, Christiaens GC.
    Prenat Diagn; 2003 Dec 30; 23(13):1042-4. PubMed ID: 14691988
    [Abstract] [Full Text] [Related]

  • 36. Early non-invasive detection of fetal Y chromosome sequences in maternal plasma using multiplex PCR.
    Kolialexi A, Tounta G, Apostolou P, Vrettou C, Papantoniou N, Kanavakis E, Antsaklis A, Mavrou A.
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar 30; 161(1):34-7. PubMed ID: 22261468
    [Abstract] [Full Text] [Related]

  • 37. Non-invasive tool for foetal sex determination in early gestational age.
    Mortarino M, Garagiola I, Lotta LA, Siboni SM, Semprini AE, Peyvandi F.
    Haemophilia; 2011 Nov 30; 17(6):952-6. PubMed ID: 21492325
    [Abstract] [Full Text] [Related]

  • 38. Prenatal diagnosis of steroid 21-hydroxylase deficiency by allele-specific amplification.
    Theodoropoulou M, Barta C, Szoke M, Guttman A, Staub M, Niederland T, Sólyom J, Fekete G, Sasvari-Szekely M.
    Fetal Diagn Ther; 2001 Nov 30; 16(4):237-40. PubMed ID: 11399887
    [Abstract] [Full Text] [Related]

  • 39. [Study on fetal SRY gene in maternal plasma using nested polymerase chain reaction].
    Hong P, Zhu PY, Huang YF, Luan JF.
    Zhonghua Nan Ke Xue; 2006 Apr 30; 12(4):333-6. PubMed ID: 16683567
    [Abstract] [Full Text] [Related]

  • 40. Clinical application of fetal sex determination using cell-free fetal DNA in pregnant carriers of X-linked genetic disorders.
    Miura K, Higashijima A, Shimada T, Miura S, Yamasaki K, Abe S, Jo O, Kinoshita A, Yoshida A, Yoshimura S, Niikawa N, Yoshiura K, Masuzaki H.
    J Hum Genet; 2011 Apr 30; 56(4):296-9. PubMed ID: 21307866
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.